ENVARSUS XR
LIVE

Serial Number

79165003

Owner

Veloxis Pharmaceuticals, Inc.

Attorney

Julia Anne Matheson

Filing Date

Oct 16, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ENVARSUS XR Trademark

Serial Number: 79165003 • Registration: 4839039

ENVARSUS XR is a trademark filed by Veloxis Pharmaceuticals, Inc. on October 16, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Veloxis Pharmaceuticals, Inc. (12 trademarks)

2000 Regency Parkway,

Entity Type: 99

Veloxis Pharmaceuticals A/S

Amerika Plads 37
Copenhagen Ø 2100 , DK

Entity Type: 03

Trademark Details

Filing Date

October 16, 2014

Registration Date

October 27, 2015

Published for Opposition

August 11, 2015

Goods & Services

[ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]

[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]

[ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and threat, diseases and afflictions in the psychiatric field, ] pulmonological diseases [ and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 11, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 11, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Sep 11, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 8, 2025 APRE
TEAS SECTION 71 RECEIVED
May 30, 2025 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 28, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
May 17, 2024 RNWL
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2023 COAR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 25, 2022 NA75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 25, 2022 APRE
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 25, 2022 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 25, 2022 APRE
REINSTATED
May 25, 2022 REIN
NOTICE OF CANCELLATION SEC. 71 E-MAILED
May 24, 2022 NC71
CANCELLED SECTION 71
May 23, 2022 C71T
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 17, 2022 EROP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2022 REAP
OFFICE ACTION ISSUED POU1
Nov 22, 2021 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 17, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Oct 26, 2021 ES75
CHANGE OF OWNER RECEIVED FROM IB
Sep 18, 2021 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 21, 2021 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2020 NREP
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sep 21, 2018 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 3, 2018 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 18, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 15, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 15, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2016 FICS
FINAL DISPOSITION PROCESSED
May 19, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2015 R.PR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sep 1, 2015 CORR
NOTIFICATION PROCESSED BY IB
Aug 21, 2015 GPNX
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 21, 2015 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 8, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2015 CRFA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 26, 2015 ADCH
ASSIGNED TO LIE
Jun 24, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2015 TROA
REFUSAL PROCESSED BY IB
Jun 13, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 26, 2015 RFCS
REFUSAL PROCESSED BY MPU
May 26, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 24, 2015 RFCR
NON-FINAL ACTION WRITTEN
May 23, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
May 19, 2015 MAFR
ASSIGNED TO EXAMINER
May 16, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2015 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 15, 2015 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 14, 2015 REPR